Cargando…
Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance
BACKGROUND: Medication nonadherence costs $300 billion annually in the US. Medicare Advantage plans have a financial incentive to increase medication adherence among members because the Centers for Medicare and Medicaid Services (CMS) now awards substantive bonus payments to such plans, based in par...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817130/ https://www.ncbi.nlm.nih.gov/pubmed/24223977 http://dx.doi.org/10.1371/journal.pone.0079611 |
_version_ | 1782478023432339456 |
---|---|
author | Zimolzak, Andrew J. Spettell, Claire M. Fernandes, Joaquim Fusaro, Vincent A. Palmer, Nathan P. Saria, Suchi Kohane, Isaac S. Jonikas, Magdalena A. Mandl, Kenneth D. |
author_facet | Zimolzak, Andrew J. Spettell, Claire M. Fernandes, Joaquim Fusaro, Vincent A. Palmer, Nathan P. Saria, Suchi Kohane, Isaac S. Jonikas, Magdalena A. Mandl, Kenneth D. |
author_sort | Zimolzak, Andrew J. |
collection | PubMed |
description | BACKGROUND: Medication nonadherence costs $300 billion annually in the US. Medicare Advantage plans have a financial incentive to increase medication adherence among members because the Centers for Medicare and Medicaid Services (CMS) now awards substantive bonus payments to such plans, based in part on population adherence to chronic medications. We sought to build an individualized surveillance model that detects early which beneficiaries will fall below the CMS adherence threshold. METHODS: This was a retrospective study of over 210,000 beneficiaries initiating statins, in a database of private insurance claims, from 2008-2011. A logistic regression model was constructed to use statin adherence from initiation to day 90 to predict beneficiaries who would not meet the CMS measure of proportion of days covered 0.8 or above, from day 91 to 365. The model controlled for 15 additional characteristics. In a sensitivity analysis, we varied the number of days of adherence data used for prediction. RESULTS: Lower adherence in the first 90 days was the strongest predictor of one-year nonadherence, with an odds ratio of 25.0 (95% confidence interval 23.7-26.5) for poor adherence at one year. The model had an area under the receiver operating characteristic curve of 0.80. Sensitivity analysis revealed that predictions of comparable accuracy could be made only 40 days after statin initiation. When members with 30-day supplies for their first statin fill had predictions made at 40 days, and members with 90-day supplies for their first fill had predictions made at 100 days, poor adherence could be predicted with 86% positive predictive value. CONCLUSIONS: To preserve their Medicare Star ratings, plan managers should identify or develop effective programs to improve adherence. An individualized surveillance approach can be used to target members who would most benefit, recognizing the tradeoff between improved model performance over time and the advantage of earlier detection. |
format | Online Article Text |
id | pubmed-3817130 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-38171302013-11-09 Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance Zimolzak, Andrew J. Spettell, Claire M. Fernandes, Joaquim Fusaro, Vincent A. Palmer, Nathan P. Saria, Suchi Kohane, Isaac S. Jonikas, Magdalena A. Mandl, Kenneth D. PLoS One Research Article BACKGROUND: Medication nonadherence costs $300 billion annually in the US. Medicare Advantage plans have a financial incentive to increase medication adherence among members because the Centers for Medicare and Medicaid Services (CMS) now awards substantive bonus payments to such plans, based in part on population adherence to chronic medications. We sought to build an individualized surveillance model that detects early which beneficiaries will fall below the CMS adherence threshold. METHODS: This was a retrospective study of over 210,000 beneficiaries initiating statins, in a database of private insurance claims, from 2008-2011. A logistic regression model was constructed to use statin adherence from initiation to day 90 to predict beneficiaries who would not meet the CMS measure of proportion of days covered 0.8 or above, from day 91 to 365. The model controlled for 15 additional characteristics. In a sensitivity analysis, we varied the number of days of adherence data used for prediction. RESULTS: Lower adherence in the first 90 days was the strongest predictor of one-year nonadherence, with an odds ratio of 25.0 (95% confidence interval 23.7-26.5) for poor adherence at one year. The model had an area under the receiver operating characteristic curve of 0.80. Sensitivity analysis revealed that predictions of comparable accuracy could be made only 40 days after statin initiation. When members with 30-day supplies for their first statin fill had predictions made at 40 days, and members with 90-day supplies for their first fill had predictions made at 100 days, poor adherence could be predicted with 86% positive predictive value. CONCLUSIONS: To preserve their Medicare Star ratings, plan managers should identify or develop effective programs to improve adherence. An individualized surveillance approach can be used to target members who would most benefit, recognizing the tradeoff between improved model performance over time and the advantage of earlier detection. Public Library of Science 2013-11-04 /pmc/articles/PMC3817130/ /pubmed/24223977 http://dx.doi.org/10.1371/journal.pone.0079611 Text en © 2013 Zimolzak et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Zimolzak, Andrew J. Spettell, Claire M. Fernandes, Joaquim Fusaro, Vincent A. Palmer, Nathan P. Saria, Suchi Kohane, Isaac S. Jonikas, Magdalena A. Mandl, Kenneth D. Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance |
title | Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance |
title_full | Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance |
title_fullStr | Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance |
title_full_unstemmed | Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance |
title_short | Early Detection of Poor Adherers to Statins: Applying Individualized Surveillance to Pay for Performance |
title_sort | early detection of poor adherers to statins: applying individualized surveillance to pay for performance |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817130/ https://www.ncbi.nlm.nih.gov/pubmed/24223977 http://dx.doi.org/10.1371/journal.pone.0079611 |
work_keys_str_mv | AT zimolzakandrewj earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance AT spettellclairem earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance AT fernandesjoaquim earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance AT fusarovincenta earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance AT palmernathanp earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance AT sariasuchi earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance AT kohaneisaacs earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance AT jonikasmagdalenaa earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance AT mandlkennethd earlydetectionofpooradhererstostatinsapplyingindividualizedsurveillancetopayforperformance |